National statements


Learn more about the Alzheimer Society of Canada’s position and perspective on a range of considerations relating to dementia, people living with dementia and their caregivers.

Alzheimer Society of Canada wordmark and identifier.

For enquiries regarding these statements and positions, please contact us at [email protected].

Cannabis and the treatment of dementia

Last updated: July 20, 2018

Summary: While there is ongoing promising research on the effects of cannabis, there is currently no evidence that cannabis is useful for the treatment or prevention of Alzheimer’s disease.

Read more.

Limbic-predominant aged-related TDP-43 encephalopathy (LATE-NC)

Last updated: May 2, 2019

Summary: The discovery of LATE-NC speaks to the growing umbrella of different dementias and the complexity of these diseases. The Alzheimer Society is hopeful that these new findings will pave the way to new treatments that target different forms of dementia.

Read more.

Meaningful engagement of people living with dementia

Last updated: August 17, 2018

Summary: The Alzheimer Society of Canada believes that people with dementia want to inform the work that directly impacts their quality of life and well-being.

The Society recognizes the right of people with dementia to be actively involved in the work of organizations that represent their interests and value their involvement.

Read more.

Medical assistance in dying (MAiD) for people living with dementia

Last updated: October 15, 2019

Summary: The Alzheimer Society respects the rights of all persons with dementia to advocate for their individual best interests, including advocating for access to MAiD through advance requests.

The Alzheimer Society provides Canadians living with dementia the support and information they need to make informed decisions about their care, including at the end of life. The Society will continue to inform persons with dementia about the legislative processes related to MAiD and any changes to the law.

We encourage those interested in this issue to read the Council of Canadian Academies’ report on medical assistance in dying.

Read more.

Online self-assessments for Alzheimer’s disease and other dementias

Last updated: May 26, 2014

Summary: Alzheimer’s disease and other dementias are complex diseases of the brain and qualified health care providers should be involved in diagnosing these conditions. People who are experiencing memory issues accompanied by difficulties in day-to-day activities and skills should contact their healthcare provider.

Read more.

Race and dementia in Canada

Last updated: October 5, 2020

Summary: At the Alzheimer Society of Canada, we work to change the lives of those living with dementia. However, we need to do more to combat systemic oppression. 

Read more.

Use of antipsychotic medications to treat people living with dementia in long-term care homes

Last updated: June 7, 2017

Statement summary: The Alzheimer Society recommends that antipsychotics only be used as a last resort to treat behavioural and psychological symptoms of dementia, especially in older adults. The Society encourages health professionals in all settings to practice a person-centred approach to care for people living with dementia.

Read more.

About us

In this section, learn more about the role and values of the Alzheimer Society of Canada, including our history of supporting Canadians living with dementia, the impact we are making today and our vision for the future.

Learn more
Alzheimer Society of Canada wordmark and identifier.